Immunisation of pigs with recombinant HEV vaccines does not protect from infection with HEV genotype 3
Hepatitis E virus (HEV) is a major cause of acute viral hepatitis worldwide. Up to now, no approved treatment nor a globally licensed vaccine is available. Several recombinant HEV vaccines have been developed to protect against HEV infection in humans, including the commercially available Hecolin va...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-06-01
|
Series: | One Health |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352771423001945 |